The U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those with a weak immune system.
would become the new primary COVID vaccine, and withdrew its emergency-use authorization for the older messenger RNA vaccines that target only the original version of coronavirus.
FDA's decision comes a day before the Centers for Disease Control and Prevention's panel of expert advisers' meeting on updating COVID-19 vaccination guidelines. The FDA authorized the bivalent COVID boosters in August that target the BA.4 and BA.5 Omicron subvariants, along with the original strain of the coronavirus.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
World Food Program warns about African food crisisThe burdens of the global food crisis aren't equally distributed worldwide: Countries in West and Central Africa are among those facing disproportionate rates of hunger, as climate change, conflict and rising costs collide.
Read more »
FDA okays second omicron booster for people at high risk from covidBreaking news: FDA clears a second omicron-targeting booster shot for people who are at high risk from the coronavirus
Read more »
Supreme Court to Decide Future of Abortion Pill MifepristoneWATCH: The FDA approved mifepristone initially some 20 years ago, but now the question is whether the FDA did it the right way, says legal analyst Dan Eaton.
Read more »
Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S.Americans seeking messenger RNA vaccines for Covid-19 for the first time will get one shot targeting both the Omicron variant and the original strain of the virus
Read more »
Abortion-pill rulings could break the FDA, drug companies sayPharmaceutical companies have mobilized against a pair of lower-court rulings restricting access to abortion pills that they contend go far beyond issues of reproductive health and pose a threat to the regulatory foundations of the U.S. drug industry.
Read more »
Sen. Cassidy dismisses Democrats’ concerns over FDA authority after abortion pill rulingSen. Bill Cassidy on Sunday described fears by Democrats that a court ruling against the abortion pill mifepristone could uproot the Food and Drug Administration’s approval of other drugs as vastly exaggerated.
Read more »